Blood lead levels and serum insulin-like growth factor 1 concentrations in peripubertal boys

Abby F Fleisch1, Jane S Burns, Paige L Williams

  • 1Department of Endocrinology, Children's Hospital Boston, Boston, Massachusetts, USA.

Insights

Childhood lead exposure, measured by blood lead levels (BLLs), is linked to lower insulin-like growth factor 1 (IGF-1) in boys. This suggests lead may impact growth by affecting the hypothalamic-pituitary-growth axis.

Area of Science:

  • Environmental Health
  • Pediatric Endocrinology
  • Toxicology

Background:

  • Childhood lead exposure is a known risk factor for growth delay.
  • The specific relationship between blood lead levels (BLLs) and insulin-like growth factor 1 (IGF-1) in low-level exposure scenarios remains under-characterized in large cohorts.

Purpose of the Study:

  • To investigate the association between baseline blood lead levels (BLLs) and serum insulin-like growth factor 1 (IGF-1) concentrations in a cohort of boys.
  • To determine if lead exposure impacts growth markers in children with low-level exposure.

Main Methods:

  • Recruited 394 boys aged 8-9 years from an industrial Russian town.
  • Employed linear regression models to assess the association between baseline BLLs and serum IGF-1 at ages 10-11 and 12-13 years.
  • Adjusted for demographic, socioeconomic, and pubertal status covariates.

Main Results:

  • A median BLL of 3 μg/dL was observed at baseline; 86% of boys were prepubertal.
  • Higher BLLs were significantly associated with lower mean serum IGF-1 concentrations at follow-up (e.g., -29.2 ng/mL difference for BLLs ≥ 5 μg/dL vs. < 5 μg/dL).
  • The inverse association between BLLs and IGF-1 was more pronounced in mid-pubertal boys and showed a dose-response relationship across different BLL categories.

Conclusions:

  • Elevated blood lead levels in peripubertal boys with low-level exposure are associated with reduced serum IGF-1.
  • Lead exposure may contribute to growth delay through potential inhibition of the hypothalamic-pituitary-growth axis.
Abstract

Related Concept Videos

Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.